{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:37:22Z","timestamp":1768678642142,"version":"3.49.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T00:00:00Z","timestamp":1371772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Transl Geriatr Exp Gerontol Rep"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s13670-013-0053-6","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T17:02:23Z","timestamp":1383757343000},"page":"196-204","source":"Crossref","is-referenced-by-count":22,"title":["Update on Dementia with Lewy Bodies"],"prefix":"10.1007","volume":"2","author":[{"given":"Stella","family":"Karantzoulis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Galvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,21]]},"reference":[{"issue":"6","key":"53_CR1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ageing\/afi190","volume":"34","author":"JC Zaccai","year":"2005","unstructured":"Zaccai JC, McCracken C, Brayne C. A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing. 2005;34(6):561\u20136.","journal-title":"Age Ageing"},{"issue":"12","key":"53_CR2","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"\u2022\u2022 McKeith IG et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863\u201372. This study outlines the latest revision of the consensus criteria on DLB.","journal-title":"Neurology"},{"key":"53_CR3","unstructured":"Shim YS, et al. Clinicopathologic study of Alzheimer's disease: Alzheimer Mimics. J Alzheimers Dis. 2013 March 12 [Epub ahead of print]."},{"issue":"3","key":"53_CR4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00415-009-5324-y","volume":"257","author":"PT Nelson","year":"2010","unstructured":"Nelson PT et al. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol. 2010;257(3):359\u201366.","journal-title":"J Neurol"},{"issue":"14","key":"53_CR5","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181bacf9e","volume":"73","author":"PT Nelson","year":"2009","unstructured":"Nelson PT et al. Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies. Neurology. 2009;73(14):1127\u201333.","journal-title":"Neurology"},{"issue":"8","key":"53_CR6","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1212\/01.wnl.0000180964.60708.c2","volume":"65","author":"DK Johnson","year":"2005","unstructured":"\u2022 Johnson DK, Morris JC, Galvin JE. Verbal and visuospatial deficits in dementia with Lewy bodies. Neurology. 2005;65(8):1232\u20138. This study examined the cognitive decline in DLB and showed that comorbid presence of DLB and AD alters the cognitive presentation of visuospatial deficits in dementia, but does not alter dementia progression.","journal-title":"Neurology"},{"issue":"2","key":"53_CR7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1468-1331.2008.02388.x","volume":"16","author":"H Hanyu","year":"2009","unstructured":"Hanyu H et al. Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease. Eur J Neurol. 2009;16(2):212\u20137.","journal-title":"Eur J Neurol"},{"issue":"10","key":"53_CR8","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/archneur.63.10.1450","volume":"63","author":"K Stavitsky","year":"2006","unstructured":"Stavitsky K et al. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease. Arch Neurol. 2006;63(10):1450\u20136.","journal-title":"Arch Neurol"},{"issue":"11","key":"53_CR9","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1212\/01.wnl.0000247041.63081.98","volume":"67","author":"MM Williams","year":"2006","unstructured":"Williams MM et al. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology. 2006;67(11):1935\u201341.","journal-title":"Neurology"},{"issue":"4","key":"53_CR10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0733-8619(05)70230-9","volume":"18","author":"IG McKeith","year":"2000","unstructured":"McKeith IG. Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. Neurol Clin. 2000;18(4):865\u2013902.","journal-title":"Neurol Clin"},{"issue":"10","key":"53_CR11","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000065889.42856.F2","volume":"60","author":"AR Merdes","year":"2003","unstructured":"Merdes AR et al. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology. 2003;60(10):1586\u201390.","journal-title":"Neurology"},{"issue":"Pt 3","key":"53_CR12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/brain\/awh725","volume":"129","author":"P Tiraboschi","year":"2006","unstructured":"Tiraboschi P et al. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain. 2006;129(Pt 3):729\u201335.","journal-title":"Brain"},{"issue":"11","key":"53_CR13","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1212\/01.WNL.0000145764.70698.4E","volume":"63","author":"UP Mosimann","year":"2004","unstructured":"Mosimann UP et al. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology. 2004;63(11):2091\u20136.","journal-title":"Neurology"},{"issue":"3","key":"53_CR14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000333072","volume":"32","author":"E Auning","year":"2011","unstructured":"Auning E et al. Early and presenting symptoms of dementia with lewy bodies. Dement Geriatr Cogn Disord. 2011;32(3):202\u20138.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"53_CR15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000072807","volume":"16","author":"D Collerton","year":"2003","unstructured":"Collerton D et al. Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord. 2003;16(4):229\u201337.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"53_CR16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1176\/appi.neuropsych.12.4.425","volume":"12","author":"M Simard","year":"2000","unstructured":"Simard M, van Reekum R, Cohen T. A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci. 2000;12(4):425\u201350.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"6","key":"53_CR17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jagp.2012.10.022","volume":"21","author":"GM Peavy","year":"2013","unstructured":"Peavy GM et al. Neuropsychiatric features of frontal lobe dysfunction in autopsy-confirmed patients with lewy bodies and \"pure\" Alzheimer disease. Am J Geriatr Psychiatry. 2013;21(6):509\u201319.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"53_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.40.1.1","volume":"40","author":"L Hansen","year":"1990","unstructured":"Hansen L et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology. 1990;40(1):1\u20138.","journal-title":"Neurology"},{"issue":"2","key":"53_CR19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jnnp.70.2.149","volume":"70","author":"R Lambon","year":"2001","unstructured":"Lambon R et al. Semantic memory is impaired in both dementia with Lewy bodies and dementia of Alzheimer's type: a comparative neuropsychological study and literature review. J Neurol Neurosurg Psychiatry. 2001;70(2):149\u201356.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"53_CR20","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007;22(12):1689\u2013707.","journal-title":"Mov Disord"},{"issue":"12","key":"53_CR21","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/01.WNL.0000165987.89198.65","volume":"64","author":"ML Kraybill","year":"2005","unstructured":"Kraybill ML et al. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both. Neurology. 2005;64(12):2069\u201373.","journal-title":"Neurology"},{"issue":"2","key":"53_CR22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000323570","volume":"31","author":"DK Johnson","year":"2011","unstructured":"Johnson DK, Galvin JE. Longitudinal changes in cognition in Parkinson's disease with and without dementia. Dement Geriatr Cogn Disord. 2011;31(2):98\u2013108.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"53_CR23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/0891988704267470","volume":"17","author":"D Aarsland","year":"2004","unstructured":"Aarsland D, Ballard CG, Halliday G. Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity? J Geriatr Psychiatry Neurol. 2004;17(3):137\u201345.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"4","key":"53_CR24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0891988703258671","volume":"16","author":"MF Weiner","year":"2003","unstructured":"Weiner MF et al. Can alzheimer's disease and dementias with Lewy bodies be distinguished clinically? J Geriatr Psychiatry Neurol. 2003;16(4):245\u201350.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"4","key":"53_CR25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/13854040500376831","volume":"20","author":"TJ Ferman","year":"2006","unstructured":"Ferman TJ et al. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease. Clin Neuropsychol. 2006;20(4):623\u201336.","journal-title":"Clin Neuropsychol"},{"issue":"Pt 2","key":"53_CR26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awf033","volume":"125","author":"AJ Harding","year":"2002","unstructured":"Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain. 2002;125(Pt 2):391\u2013403.","journal-title":"Brain"},{"issue":"1","key":"53_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","volume":"3","author":"I McKeith","year":"2004","unstructured":"McKeith I et al. Dementia with Lewy bodies. Lancet Neurol. 2004;3(1):19\u201328.","journal-title":"Lancet Neurol"},{"issue":"7","key":"53_CR28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1176\/ajp.156.7.1039","volume":"156","author":"C Ballard","year":"1999","unstructured":"Ballard C et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. Am J Psychiatry. 1999;156(7):1039\u201345.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"53_CR29","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1212\/WNL.47.5.1148","volume":"47","author":"LA Klatka","year":"1996","unstructured":"Klatka LA, Louis ED, Schiffer RB. Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology. 1996;47(5):1148\u201352.","journal-title":"Neurology"},{"issue":"22","key":"53_CR30","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1212\/01.wnl.0000263131.80945.ad","volume":"68","author":"JE Galvin","year":"2007","unstructured":"Galvin JE et al. Personality traits distinguishing dementia with Lewy bodies from Alzheimer disease. Neurology. 2007;68(22):1895\u2013901.","journal-title":"Neurology"},{"issue":"11","key":"53_CR31","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1212\/01.WNL.0000036908.39696.FD","volume":"59","author":"CG Ballard","year":"2002","unstructured":"Ballard CG et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology. 2002;59(11):1714\u201320.","journal-title":"Neurology"},{"issue":"Pt 11","key":"53_CR32","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/brain\/awm056","volume":"130","author":"BF Boeve","year":"2007","unstructured":"Boeve BF et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130(Pt 11):2770\u201388.","journal-title":"Brain"},{"issue":"6855","key":"53_CR33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bmj.305.6855.673","volume":"305","author":"I McKeith","year":"1992","unstructured":"McKeith I et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ. 1992;305(6855):673\u20138.","journal-title":"BMJ"},{"issue":"5","key":"53_CR34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4088\/JCP.v66n0514","volume":"66","author":"D Aarsland","year":"2005","unstructured":"Aarsland D et al. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry. 2005;66(5):633\u20137.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"53_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/153331750201700106","volume":"17","author":"S Rogan","year":"2002","unstructured":"Rogan S, Lippa CF. Alzheimer's disease and other dementias: a review. Am J Alzheimers Dis Other Demen. 2002;17(1):11\u20137.","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"9","key":"53_CR36","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/01.wnl.0000242630.52203.8f","volume":"67","author":"JE Galvin","year":"2006","unstructured":"Galvin JE et al. Clinical phenotype of Parkinson's disease dementia. Neurology. 2006;67(9):1605\u201311.","journal-title":"Neurology"},{"issue":"22","key":"53_CR37","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1212\/01.wnl.0000335972.35970.70","volume":"71","author":"K Johnson","year":"2008","unstructured":"Johnson K et al. Cognitive profils in dementia: Alzheimer disease versus nondemented aging. Neurology. 2008;71(22):1783\u20139.","journal-title":"Neurology"},{"issue":"12","key":"53_CR38","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.wnl.0000219812.20616.b3","volume":"66","author":"BK Woodruff","year":"2006","unstructured":"Woodruff BK et al. Family history of dementia is a risk factor for Lewy body disease. Neurology. 2006;66(12):1949\u201350.","journal-title":"Neurology"},{"issue":"1","key":"53_CR39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ajmg.b.30014","volume":"128B","author":"AJ Harding","year":"2004","unstructured":"Harding AJ et al. Identification of families with cortical Lewy body disease. Am J Med Genet B Neuropsychiatr Genet. 2004;128B(1):118\u201322.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"8","key":"53_CR40","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/archneurol.2010.177","volume":"67","author":"K Nishioka","year":"2010","unstructured":"\u2022\u2022 Nishioka K et al. Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease. Arch Neurol. 2010;67(8):970\u20135. This study showed that variants in all three members of the synuclein gene family affect the risk of developing DLBD and warrant further investigation in larger, pathologically defined data sets.","journal-title":"Arch Neurol"},{"issue":"2","key":"53_CR41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/349","volume":"1","author":"VL Buchman","year":"1998","unstructured":"Buchman VL et al. Persyn, a member of the synuclein family, influences neurofilament network integrity. Nat Neurosci. 1998;1(2):101\u20133.","journal-title":"Nat Neurosci"},{"issue":"2","key":"53_CR42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai A et al. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 1995;14(2):467\u201375.","journal-title":"Neuron"},{"issue":"5","key":"53_CR43","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/01.WNL.0000139870.14385.3C","volume":"63","author":"H Ohtake","year":"2004","unstructured":"Ohtake H et al. Beta-synuclein gene alterations in dementia with Lewy bodies. Neurology. 2004;63(5):805\u201311.","journal-title":"Neurology"},{"issue":"3","key":"53_CR44","doi-asserted-by":"crossref","first-page":"629 e5","DOI":"10.1016\/j.neurobiolaging.2011.10.014","volume":"33","author":"B Meeus","year":"2012","unstructured":"Meeus B et al. DLB and PDD: a role for mutations in dementia and Parkinson disease genes? Neurobiol Aging. 2012;33(3):629 e5\u201318.","journal-title":"Neurobiol Aging"},{"key":"53_CR45","first-page":"1","volume":"15","author":"MA Nalls","year":"2013","unstructured":"\u2022 Nalls MA, Duran R, Lopez G, et al. A multicenter study of glucocerebrosidase mutations in dementia with lewy bodies. JAMA Neurol. 2013;15:1\u20139. doi: 10.1001\/jamaneurol.2013.1925 . [Epub ahead of print] This study is the largest to date linking mutations in Glucocerebrosidase to DLB.","journal-title":"JAMA Neurol"},{"issue":"3","key":"53_CR46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneurol.2007.68","volume":"65","author":"IF Mata","year":"2008","unstructured":"Mata IF et al. Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch Neurol. 2008;65(3):379\u201382.","journal-title":"Arch Neurol"},{"issue":"Pt 9","key":"53_CR47","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/brain\/awm167","volume":"130","author":"V Bogaerts","year":"2007","unstructured":"Bogaerts V et al. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. Brain. 2007;130(Pt 9):2277\u201391.","journal-title":"Brain"},{"issue":"Pt 3","key":"53_CR48","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/brain\/awl388","volume":"130","author":"JL Whitwell","year":"2007","unstructured":"Whitwell JL et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain. 2007;130(Pt 3):708\u201319.","journal-title":"Brain"},{"issue":"4","key":"53_CR49","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/jcbfm.2013.2","volume":"33","author":"SJ Colloby","year":"2013","unstructured":"\u2022 Colloby SJ et al. Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: utility in differential diagnosis. J Cereb Blood Flow Metab. 2013;33(4):612\u20138. This study showed that multivariate analysis of blood flow SPECT data is robust and shows good diagnostic accuracy in two independent cohorts for distinguishing DLB from AD.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"53_CR50","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.1133","volume":"50","author":"S Minoshima","year":"2001","unstructured":"Minoshima S et al. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol. 2001;50(3):358\u201365.","journal-title":"Ann Neurol"},{"issue":"10","key":"53_CR51","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.109.065870","volume":"50","author":"SM Lim","year":"2009","unstructured":"Lim SM et al. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. J Nucl Med. 2009;50(10):1638\u201345.","journal-title":"J Nucl Med"},{"issue":"12","key":"53_CR52","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1468-1331.2007.01977.x","volume":"14","author":"SW Yong","year":"2007","unstructured":"Yong SW et al. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies. Eur J Neurol. 2007;14(12):1357\u201362.","journal-title":"Eur J Neurol"},{"issue":"6","key":"53_CR53","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archneur.61.6.919","volume":"61","author":"JT O'Brien","year":"2004","unstructured":"O'Brien JT et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol. 2004;61(6):919\u201325.","journal-title":"Arch Neurol"},{"issue":"2","key":"53_CR54","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/jnnp.73.2.134","volume":"73","author":"Z Walker","year":"2002","unstructured":"Walker Z et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry. 2002;73(2):134\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"53_CR55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","volume":"6","author":"I McKeith","year":"2007","unstructured":"McKeith I et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6(4):305\u201313.","journal-title":"Lancet Neurol"},{"issue":"6","key":"53_CR56","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1017\/S1041610208007709","volume":"20","author":"SJ Colloby","year":"2008","unstructured":"Colloby SJ et al. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies. Int Psychogeriatr. 2008;20(6):1124\u201340.","journal-title":"Int Psychogeriatr"},{"issue":"10","key":"53_CR57","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1212\/WNL.55.10.1575","volume":"55","author":"XS Hu","year":"2000","unstructured":"Hu XS et al. 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies. Neurology. 2000;55(10):1575\u20137.","journal-title":"Neurology"},{"issue":"1 Suppl 1","key":"53_CR58","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jalz.2007.11.016","volume":"4","author":"RA Koeppe","year":"2008","unstructured":"Koeppe RA et al. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography. Alzheimers Dement. 2008;4(1 Suppl 1):S67\u201376.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"53_CR59","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1468-1331.2010.03040.x","volume":"17","author":"J Hort","year":"2010","unstructured":"Hort J et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol. 2010;17(10):1236\u201348.","journal-title":"Eur J Neurol"},{"issue":"12","key":"53_CR60","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","volume":"79","author":"P Edison","year":"2008","unstructured":"Edison P et al. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry. 2008;79(12):1331\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"53_CR61","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","volume":"71","author":"SN Gomperts","year":"2008","unstructured":"Gomperts SN et al. Imaging amyloid deposition in Lewy body diseases. Neurology. 2008;71(12):903\u201310.","journal-title":"Neurology"},{"issue":"1","key":"53_CR62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1185\/030079906X80279","volume":"22","author":"J Touchon","year":"2006","unstructured":"Touchon J et al. Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology. Curr Med Res Opin. 2006;22(1):49\u201359.","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"53_CR63","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1099-1166(200009)15:9<794::AID-GPS178>3.0.CO;2-1","volume":"15","author":"W Samuel","year":"2000","unstructured":"Samuel W et al. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry. 2000;15(9):794\u2013802.","journal-title":"Int J Geriatr Psychiatry"},{"key":"53_CR64","volume":"3","author":"M Rolinski","year":"2012","unstructured":"Rolinski M, Fox C, Maidment I, McShane R. Cholinesterase inhibitors for dementia with Lewy bodies. Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database Syst Rev. 2012;3, CD006504. doi: 10.1002\/14651858.CD006504.pub2 .","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"53_CR65","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/01.wnl.0000172351.95783.8e","volume":"65","author":"BH Ridha","year":"2005","unstructured":"Ridha BH, Josephs KA, Rossor MN. Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine. Neurology. 2005;65(3):481\u20132.","journal-title":"Neurology"},{"issue":"4","key":"53_CR66","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/JAD-2005-7403","volume":"7","author":"MN Sabbagh","year":"2005","unstructured":"Sabbagh MN et al. The use of memantine in dementia with Lewy bodies. J Alzheimers Dis. 2005;7(4):285\u20139.","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"53_CR67","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.2004.052332","volume":"76","author":"S Molloy","year":"2005","unstructured":"Molloy S et al. The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2005;76(9):1200\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"53_CR68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2125.2004.01799.x","volume":"58","author":"CS Okereke","year":"2004","unstructured":"Okereke CS et al. Concurrent administration of donepezil HCl and levodopa\/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Br J Clin Pharmacol. 2004;58 Suppl 1:41\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"9247","key":"53_CR69","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","volume":"356","author":"I McKeith","year":"2000","unstructured":"McKeith I et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet. 2000;356(9247):2031\u20136.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"53_CR70","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.parkreldis.2003.12.005","volume":"10","author":"IG McKeith","year":"2004","unstructured":"McKeith IG, Mosimann UP. Dementia with Lewy bodies and Parkinson's disease. Parkinsonism Relat Disord. 2004;10 Suppl 1:S15\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"53_CR71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v60n0207","volume":"60","author":"IR Katz","year":"1999","unstructured":"Katz IR et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry. 1999;60(2):107\u201315.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"53_CR72","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/(SICI)1099-1166(199906)14:6<459::AID-GPS957>3.0.CO;2-R","volume":"14","author":"Z Walker","year":"1999","unstructured":"Walker Z et al. Olanzapine in dementia with Lewy bodies: a clinical study. Int J Geriatr Psychiatry. 1999;14(6):459\u201366.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"53_CR73","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/089198870201500307","volume":"15","author":"JH Friedman","year":"2002","unstructured":"Friedman JH, Fernandez HH. Atypical antipsychotics in Parkinson-sensitive populations. J Geriatr Psychiatry Neurol. 2002;15(3):156\u201370.","journal-title":"J Geriatr Psychiatry Neurol"}],"container-title":["Current Translational Geriatrics and Experimental Gerontology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13670-013-0053-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13670-013-0053-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13670-013-0053-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T06:55:38Z","timestamp":1688626538000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13670-013-0053-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,21]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1007\/s13670-013-0053-6","relation":{},"ISSN":["2162-4941"],"issn-type":[{"value":"2162-4941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,21]]}}}